Europe Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users)

The Europe oligonucleotide synthesis market is expected to reach US$ $ 1,270.95 Mn in 2027 from US$ 518.02 Mn in 2018. The market is estimated to grow with a CAGR of 13.7% from 2019-2027.
The growth of the oligonucleotide synthesis market is primarily attributed to the partnerships and collaborations undertaken by the market players as well as increasing venture capital investments in pharmaceutical and biotechnology companies. However, the growth of the market is restrained by factors such as frequently changing EU regulatory policies for biotechnology industry and European biotechnology sector lacks skilled professionals. On the other hand, new product development and rising investments by pharmaceutical and biotechnology companies is likely to have a positive impact on the growth of the Europe Oligonucleotide Synthesis market in the coming years. 
There are various start-up companies that are providing the products/services for the biological processes. Synthetic biology has numerous applications in the chemical, agriculture, pharmaceutical and energy sectors. Companies such as, Ginkgo Bioworks works for the organism engineering, GenScript offers gene synthesis, Benchling which operates in CAD Tools, Transcriptis which is into bioinformatics operates for cloud labs/automation, Glowee offers consumer products, among the other companies operating in the synthetic biology. 
Globally, the synthetic biology has set benchmark with its innovations and the dynamic results. Global leaders in biopharmaceutical industry are investing heavily in synthetic biology. For instance, synthetic DNA manufacturer DNA Script has announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures, with additional investment from Merck Ventures BV, the corporate venture arm of Merck KGaA, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners. 
Furthermore, in July 2018, Evonetix Awarded Innovate UK Funding for ?1.3 million ($1.75M) Gene Synthesis Project. Innovate UK, the UK?s innovation agency, will co-fund the ?1.3 million project, which will be undertaken in collaboration with Durham University. Owing to the rising investment for the synthetic biology companies, the need and demand for the synthetic biology for the development of the new techniques may increase the market in the future years.
In 2018, the synthesized oligonucleotides segment held a largest market share of 48.2% of the oligonucleotide synthesis market, by product. This segment is also expected to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the reagent segment held a largest market share of 45.2% of the oligonucleotide synthesis market, by application. This segment is also expected to dominate the market in 2027 owing to availability of funds as well as supportive government policies. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the academic research institutes segment held a largest market share of 45.3% of the oligonucleotide synthesis market, by end user. This segment is also expected to dominate the market in 2027. However, the diagnostic laboratories segment is anticipated to witness the fastest growth rate of 12% during the forecast period. This higher growth rate of the segment can be attributed to the efficiency of oligonucleotides for diagnostic process.
Some of the major primary and secondary sources for western blotting included in the report are, Ludwig-Maximilians-Universit?t M?nchen (LMU), Technical University Munich (TUM), Association For Responsible Research And Innovation In Genome Editing (ARRIGE), Biotechnology And Biological Sciences Research Council (BBSRC), Genetically Modified Crops And Organisms (GMOs), Cancer Genomics And Advanced Therapeutics (C-CAT) and others.
TABLE OF CONTENTS
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Europe Oligonucleotide Synthesis Market - Key Takeaways
3. Europe Oligonucleotide Synthesis Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Oligonucleotide Synthesis Market - By Product
3.2.2 Europe Oligonucleotide Synthesis Market - By Application
3.2.3 Europe Oligonucleotide Synthesis Market - By End User
3.2.4 Europe Oligonucleotide Synthesis Market - By Country
3.3 PEST Analysis
3.3.1 Europe - PEST Analysis
4. Europe Oligonucleotide Synthesis Market-Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Heavy Investments by European Private Players in Synthetic Biology
4.1.2 Synthesized Oligonucleotides to Treat Medical Conditions
4.1.3 Rising Number of Research and Development Activities in Synthetic Biology
4.2 Key Market Restraints
4.2.1 Frequently Changing EU Regulatory Policies for Biotechnology Industry
4.2.2 Biotechnology Sector Lacks Skilled Professionals
4.3 Key Market Opportunities
4.3.1 Collaborations ? The Future of Innovation
4.4 Future Trends
4.4.1 New Product Developments in Synthetic Biology
4.5 Impact Analysis
5. Oligonucleotide Synthesis - Europe Analysis
5.1 Europe Oligonucleotide Synthesis Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
5.3.1 Thermo Fisher Scientific Inc.
5.3.2 GenScript
5.4 Expert Opinions
6. Europe Oligonucleotide Synthesis Market Analysis -By Product
6.1 Overview
6.2 Europe Oligonucleotide Synthesis Market, By Product, 2018 & 2027 (%)
6.3 Synthesized Oligonucleotides Market
6.3.1 Overview
6.3.2 Europe Synthesized Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.3 Primers Market
6.3.3.1 Overview
6.3.3.2 Europe Primers Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4 Probes Market
6.3.4.1 Overview
6.3.4.1.1 Europe Probes Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.2 Large-Scale Synthesis Oligonucleotides Market
6.3.4.2.1 Overview
6.3.4.2.2 Europe Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.3 Others Market
6.3.4.3.1 Overview
6.3.4.3.2 Europe Others Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 Reagents Market
6.4.1 Overview
6.4.2 Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Equipment Market
6.5.1 Overview
6.5.2 Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
7. Europe Oligonucleotide Synthesis Market Analysis - By Application
7.1 Overview
7.2 Europe Oligonucleotide Synthesis Market, By Application, 2018 & 2027 (%)
7.3 Research Market
7.3.1 Overview
7.3.2 Europe Research Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Diagnostics Market
7.4.1 Overview
7.4.2 Europe Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Therapeutics Market
7.5.1 Overview
7.5.2 Europe Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Oligonucleotide Synthesis Market Analysis -By End User
8.1 Overview
8.2 Europe Oligonucleotide Synthesis Market, By End User, 2018 & 2027 (%)
8.3 Academic Research Institutes Market
8.3.1 Overview
8.3.2 Europe Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Diagnostic Laboratories Market
8.4.1 Overview
8.4.2 Europe Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Pharmaceutical & Biotechnology Companies Market
8.5.1 Overview
8.5.2 Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Other End Users Market
8.6.1 Overview
8.6.2 Europe Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027
9.1 Overview
9.1.1 Europe Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.2.1 Europe Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.3 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.4 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 Europe Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.1.6 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.6.2.1 UK Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6.4 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.7.2.1 Germany Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 France Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 France Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.8.2.1 France Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.9 Italy Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.9.2.1 Italy Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.3 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.9.4 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.10 Spain Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.1 Spain Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.2 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.10.2.1 Spain Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.10.3 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.10.4 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. Oligonucleotide Synthesis Market -Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done By The Companies In The Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Oligonucleotide Synthesis Market-Key Company Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 GenScript
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Synthomics, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Ansa Biotechnologies, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Iridia, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Helixworks
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Keasling Lab
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Molecular Assemblies
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Twist Bioscience
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Evonetix
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Dna Script
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 Nuclera Nucleics Ltd.
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Financial Overview
11.12.4 Product Portfolio
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 Camena Bio
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Financial Overview
11.13.4 Product Portfolio
11.13.5 SWOT Analysis
11.13.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research

LIST OF TABLES Table 1. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn) Table 2. Europe Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn) Table 3. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn) Table 4. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn) Table 5. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn) Table 6. UK Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn) Table 7. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn) Table 8. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn) Table 9. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn) Table 10. Germany Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn) Table 11. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn) Table 12. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn) Table 13. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn) Table 14. France Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn) Table 15. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn) Table 16. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn) Table 17. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn) Table 18. Italy Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn) Table 19. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn) Table 20. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn) Table 21. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn) Table 22. Spain Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn) Table 23. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn) Table 24. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn) Table 25. Organic Developments Done By Companies Table 26. Inorganic Developments Done By Companies Table 27. Glossary Of Terms, Oligonucleotide Synthesis Market

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by The Insight Partners

North America Biodegradable Plastic Market to 2027 - Regional Analysis and Forecasts by Type (PHA, PLA, Starch Blends, Biodegradable Polyesters, Others); End User (Packaging and Bags, Agriculture and Horticulture, Consumer Goods, Textile, Others), and Country

The North America biodegradable plastic market is accounted to US$ 806.9 Mn in 2018 and is expected to grow at a CAGR of 14.0% during the forecast period 2019 - 2027, to account to US$ 2,622.4 Mn by 2027. The North America biodegradable plastic mar...

North America Meat Snacks Market to 2027 - Regional Analysis and Forecasts by Type (Jerky, Sticks, Strips & Bites, Bars, Sausages, Others); Nature (Organic, Conventional); Sales (Direct, Indirect); Flavour (Original, Pepperoni, Spicy Red Pepper, Others); Source (Beef, Pork, Turkey, Others) and Country

The North America meat snacks market is accounted to US$ 3,254.2 Mn in 2018 and is expected to grow at a CAGR of 7.2% during the forecast period 2019 - 2027, to account to US$ 6,036.5 Mn by 2027. Meat snacks are defined as popular convenience snackin...

Asia Pacific Biodegradable Plastic Market to 2027 - Regional Analysis and Forecasts by Type (PLA, PHA, Starch Blends, PBS, PBAT, and Others), End User (Packaging and Bags, Agriculture & Horticulture, Consumer Goods, and Others), and Countries

The Asia Pacific biodegradable plastic market is accounted to US$ 731.0 Mn in 2018 and is expected to grow at a CAGR of 16.6% during the forecast period 2019 - 2027, to account to US$ 2,916.1 Mn by 2027. The Asia Pacific biodegradable plastic market ...

Europe Biodegradable Plastic Market to 2027 - Regional Analysis and Forecasts by Type (PLA, PHA, Starch Blends, PBS, PBAT, and Others), End User (Packaging and Bags, Agriculture & Horticulture, Consumer Goods, and Others), and Countries

The Europe biodegradable plastic market is accounted to US$ 980.0 Mn in 2018 and is expected to grow at a CAGR of 14.4% during the forecast period 2019 - 2027, to account to US$ 3,286.9 Mn by 2027. The Europe biodegradable plastic market is segmented...

Dried Cranberry Market to 2027 - Global Analysis and Forecasts by Product Type (Freeze Dried, Sun Dried, Infused Dried, and Others), Nature (Conventional and Organic), End Use (Bakery Products, Confectionaries, Dairy Products, Beverages, Cereal & Snack Bars, and Others), Distribution Channel (Supermarkets & Hypermarket, Convenience Store, Online, and Others)

The global dried cranberry market accounted for US$ 170.4 in 2018 and is expected to grow at a CAGR of 4.7% during the forecast period 2019 - 2027, to account for US$ 256.2 Mn by 2027. Dried cranberries are made by partially dehydrating fresh cranber...

New Biotechnology Reports

Publisher: The Insight Partners 163 Pages